Cypress Capital Group Baxter International Inc Transaction History

Cypress Capital Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$64.48 - $81.31 $275,974 - $348,006	-4,280 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$70.71 - $77.75 $1,414 - $1,555	-20 Reduced 0.47%	4,280 $330,000
Q2 2018 Aug 15, 2018	SELL	$63.43 - $75.41 $144,049 - $171,256	-2,271 Reduced 34.56%	4,300 $317,000
Q1 2018 May 21, 2018	SELL	$62.56 - $72.26 $52,112 - $60,192	-833 Reduced 11.25%	6,571 $428,000
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $98,320 - $105,680	1,600 Added 27.57%	7,404 $479,000
Q3 2017 Nov 16, 2017	BUY	$59.5 - $64.61 $137,088 - $148,861	2,304 Added 65.83%	5,804 $364,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,500	3,500 $211,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.